BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28641617)

  • 1. [Biological Characteristics and Therapeutic Efficacy of 103 Patients with Acute Erythroleukemia].
    Yin Y; Zhan WQ; Huang HF; Zhang CQ; Fu DH; Xu SJ; Hu JD; Chen XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):678-682. PubMed ID: 28641617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of clinical characteristics and prognosis of 13 cases of acute erythroleukemia].
    Guo YL; Zhou MH; Cao TT; Dou LP; Lu XL; Zhang QF; Yao ZL; Wang LL; Yu L; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1142-7. PubMed ID: 24156422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Prognosis of 167 Cases of Acute Erythroleukemia.
    Ma ZQ; Pan JH; Jing DX; Xu CY
    Indian J Hematol Blood Transfus; 2017 Mar; 33(1):56-60. PubMed ID: 28194057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and prognoses of 167 acute erythroleukemia patients].
    Cheng W; Sun A; Chen S; Qiu H; Yin J; Ping N; Wang Q; Wu D
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):970-3. PubMed ID: 25417871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factor analysis of 77 old patients with acute myelogenous leukemia].
    Shao B; Gao YR; Wang C; Yan SK; Cai Q; Jiang JL; Yang J; Bai HT; Zhao M; Zhao CX
    Ai Zheng; 2006 Aug; 25(8):1007-12. PubMed ID: 16965684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of Philadelphia chromosome-positive adult acute lymphoblastic leukemia].
    Zhang YF; Chen ZM; Lou JY; Ni WM; Wang YG; Meng HT; Tong HY; Qian WB; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):814-8. PubMed ID: 22339953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical Features and Prognosis of 227 cases of Acute Myeloid Leukemia with Cross-lineage Antigen Expression].
    Fang F; Zhu P; Zhang Y; Lu XZ; Dong YJ; Sun YH; Wang LH; Bu DF; Cen XN; Wang MJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):990-7. PubMed ID: 27531762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML).
    Lamy T; Goasguen JE; Mordelet E; Grulois I; Dauriac C; Drenou B; Chaperon J; Fauchet R; le Prise PY
    Leukemia; 1994 Nov; 8(11):1879-83. PubMed ID: 7526090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
    Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features and early treatment effects in intermediate risk and poor risk acute myeloid leukemia with EVI1 positive].
    Duan WB; Gong LZ; Jia JS; Zhu HH; Zhao XS; Jiang Q; Zhao T; Wang J; Qin YZ; Huang XJ; Jiang H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):990-995. PubMed ID: 29263470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry (CyTOF).
    Maag AH; Swanton H; Kull M; Vegi NM; Feuring M
    Cytometry A; 2023 Jul; 103(7):551-562. PubMed ID: 36647792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [IDH1 Gene Mutation and Its Clinical Significance in patients with Acute Myeloid Leukemia].
    Wei JF; Qiu HY; Chen GH; Wang Y; Chen Z; Liu HJ; Mao JP; Jia T; Xue LG; Cai ZM; Zhu YX; Zhao LD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1252-7. PubMed ID: 26524018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical and laboratory features of acute promyelocytic leukemia: an analysis of 513 cases].
    Liang JY; Wu DP; Liu YJ; Ma QF; Gong JX; Zhu MQ; Xue YQ; Chen ZX
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):389-92. PubMed ID: 18953948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
    Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.
    Iriyama N; Asou N; Miyazaki Y; Yamaguchi S; Sato S; Sakura T; Maeda T; Handa H; Takahashi M; Ohtake S; Hatta Y; Sakamaki H; Honda S; Taki T; Taniwaki M; Miyawaki S; Ohnishi K; Kobayashi Y; Naoe T
    Ann Hematol; 2014 Jun; 93(6):957-63. PubMed ID: 24441947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic Significance of CD45
    Sun Q; Zhang HX; Hu CY; Han YH; Bu XT; Li HJ; Li ZY; Yan ZL; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):702-707. PubMed ID: 31204919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.